Our finding that hydroxylated HIF-1α in primary breast cancer is associated with significantly poorer survival (unlike total HIF-1α) suggests that a more moderate level of hypoxia that allows for continued HIF-1α hydroxylation may favour malignant progression. The gene discussed is HIF1A; the disease is breast carcinoma.